If you didn't find what you were looking for, try a new search!
On Oct. 28, 2024, Neurovalens announced it launched its first product, Modius Sleep, an FDA-cleared, physician-prescribed medical device intended to treat chronic insomnia in adults. About Modius Sleep Modius Sleep is a portable, battery-operated neurostimulation device worn on the head for 30 minutes each [...]
Insomnia continues to be a common sleep disorder affecting ~10% of adults, with ~20% experiencing occasional insomnia. It is often a chronic condition with a 40% persistence rate over a 5-year period. Members of the Emerging Technology Committee share non-pharmacologic treatments for insomnia. [...]
Webinar Registration: The Technology Tuck In: Insomnia Treatments NOVEMBER 1 @ 1:00 PM - 2:00 PM EST View event Members only event
By Shalini Paruthi, MD, FAASM; Steven Holfinger, MD, MS; Sachin Shah, MD, MS; Evin Jerkins, DO; Christine Won, MD; Sharon Schutte-Rodin, MD, FAASM; on behalf of the AASM Emerging Technology Committee Keeping up with diverse and numerous insomnia-related devices and products can be challenging [...]
Season 6 | Episode 18 DRS. LEISHA CUDDIHY, SARA NOWAKOWSKI, AND MICHAEL GRANDNER, GUESTS We have long known about the bi-directional relationship between anxiety and insomnia, and traditionally we’ve been taught that treating anxiety will treat insomnia. Since that time, more data have [...]
On Aug. 8, 2024, Big Health announced it received FDA clearance for its digital therapeutic, SleepioRx, for the treatment of chronic insomnia as an adjunct to usual care in adults. About SleepioRx SleepioRx is a prescription device that delivers cognitive behavioral therapy for [...]
Season 6 | Episode 14 DRS. SHALINI PARUTHI AND SACHIN SHAH, GUESTS As technology continues to permeate every aspect of our lives, the subset of sleep-related technology continues to expand. The AASM Emerging Technology committee continues to assess both clinical and consumer sleep [...]
Insomnia Toolkit for Clinicians Insomnia disorder is associated with substantial burden that impacts patients, providers, payers, health systems, and society at large. As a foundational step toward improving access to high-quality insomnia care, the American Academy of Sleep Medicine (AASM) convened key stakeholders [...]
DARIEN, IL – In a new survey commissioned by the American Academy of Sleep Medicine, 12% of Americans said they have been diagnosed with chronic insomnia. Thursday, June 20, is the 11th annual Insomnia Awareness Night, held by the American Academy of Sleep [...]
Summary Somnio Insomnia Therapy is an online, self-directed, 8-session course focused on improving the user’s sleep pattern and sleep environment, identifying and adjusting lifestyle habits, learning to recognize and change negative beliefs and thoughts, reinforcing positive beliefs and thoughts, and learning techniques that help [...]
Season 6 | Episode 5 DR. CHRIS BOJRAB, GUEST We know that CBT-I is the gold standard treatment for insomnia, but it remains inaccessible for many due to cost or the limited availability of trained professionals. For patients with comorbid mental health disorders, [...]
Sachin Shah, MD, MS; Sharon Schutte-Rodin, MD, DABSM, FAASM; Shalini Paruthi, M.D.; Ambrose Chiang, MD, FAASM; Makayla Cordoza, PhD, RN, CCRN-K; Kevin Gipson, MD; Evin Jerkins, DO; Eric J. Olson, MD on behalf of the AASM Emerging Technology Committee The AASM recommends clinicians use [...]
Neurovalens announced Oct. 31 it has received FDA 510(k) clearance for its Modius Sleep device intended to treat chronic insomnia. By delivering a small and safe electrical pulse to the head for 30 minutes before bed, Modius Sleep is designed to improve insomnia. [...]
Talking Sleep Season 5 | Episode 16 DREAM-IT: Insomnia Management in Adolescents Dr. Maureen Elizabeth McQuillan and Dr. Sarah Morsbach Honaker, GUESTS As students go back to school, many adolescents will have to advance their sleep phase in order to start classes early [...]
DARIEN, IL - More than half of Americans “always” or “often” have trouble falling asleep (54%) or staying asleep (53%), according to a new survey commissioned by the American Academy of Sleep Medicine. On Wednesday, June 21, the “shortest night of the year,” the AASM will hold [...]
Talking Sleep Season 5 | Episode 4 Comorbid insomnia and sleep apnea (COMISA) Dr. Alexander Sweetman, GUEST An article published in ERJ Open Research demonstrates that cognitive behavioral therapy for insomnia (CBT-I) consolidates sleep periods and promotes a 15% decrease in OSA severity [...]
DARIEN, IL – Nearly 3 in 10 Americans (28%) say insomnia has a negative impact on their daily lives, according to a new survey from the American Academy of Sleep Medicine (AASM). On Tuesday, June 21, the “shortest night of the year,” the AASM [...]
On Jan. 10, 2022, Idorsia announced that the FDA approved QUVIVIQ (daridorexant) 25 mg and 50 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. About QUVIVIQ QUVIVIQ is a prescription medication indicated for [...]
By Jack Edinger, PhD, Chair, Behavioral and Psychological Treatments for Insomnia Guideline Task Force Chronic insomnia disorder is a widespread and debilitating condition that affects quality of life, daytime functioning, mental and physical health, and health care utilization for millions worldwide. The International Classification [...]
June 22 observance will drive attention to symptoms and consequences of chronic insomnia DARIEN, Ill. –The American Academy of Sleep Medicine and the Society of Behavioral Sleep Medicine are working to raise awareness of one of the most common sleep problems with Insomnia Awareness [...]
Stressful days and sleepless nights leave many people searching for a quick solution to their sleep troubles – is melatonin the answer? As the coronavirus pandemic enters its second year, stress and anxiety are leaving many American adults struggling to get sufficient, quality [...]
DARIEN, IL – The American Academy of Sleep Medicine has published a new clinical practice guideline establishing recommendations for the use of behavioral and psychological treatments for chronic insomnia disorder in adults. The guideline includes one strong recommendation — which is one that clinicians [...]
DARIEN, IL – A study found a significant increase in the number of online search queries for “insomnia” between April and May 2020, when governments across the U.S. and around the world implemented stay-at-home orders in response to the COVID-19 pandemic. Results show there [...]
DARIEN, IL – Weighted blankets are a safe and effective intervention in the treatment of insomnia, according to Swedish researchers who found that insomnia patients with psychiatric disorders experienced reduced insomnia severity, improved sleep and less daytime sleepiness when sleeping with a weighted chain [...]
DARIEN, IL – June features the shortest nights of the year, but for those living with chronic insomnia, every night is long. That’s why the American Academy of Sleep Medicine (AASM), Society of Behavioral Sleep Medicine (SBSM) and American Alliance for Healthy Sleep (AAHS) [...]
The American Academy of Sleep Medicine (AASM) is inviting public comment on drafts of a clinical practice guideline on the Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults and accompanying systematic review. The public comment period is open for 4 weeks [...]
The U.S. Food and Drug Administration has cleared the first prescription-based digital therapeutic for the treatment of chronic insomnia in adults, according to a press release from the product developer, Pear Therapeutics. Somryst, formerly SHUTi, uses cognitive behavioral therapy and data-based sleep restrictions to [...]
Merck announced Feb. 3, 2020, that the U.S. Food and Drug Administration has updated the prescribing information for Belsomra (suvorexant) to include details about an insomnia study in patients with mild to moderate Alzheimer’s disease. Belsomra was first FDA-approved for the treatment of insomnia [...]
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced that the U.S. Food and Drug Administration has approved Dayvigo (lemborexant) 5 mg and 10 mg for the treatment of adult patients with sleep-onset insomnia and sleep maintenance insomnia. According to Eisai, the [...]
Insomnia in Children Health Advisory Behavioral interventions should be the first treatment option for healthy children who struggle with bedtime resistance or nighttime awakenings. For those who fail to respond, or for children with more complex medical problems, evaluation by a sleep physician [...]
Question: What code is used for cognitive behavioral therapy for insomnia (CBT-I)? Answer: There are three different code series that can be used to report cognitive behavioral therapy for insomnia (CBT-I). Some providers report evaluation and management (E/M) codes for new and established patients, [...]
SAN ANTONIO – Preliminary findings from two analyses of an ongoing study suggest that cognitive behavioral therapy for insomnia delivered by telemedicine is as effective as face-to-face delivery. Results of a randomized controlled non-inferiority trial show that both delivery methods were equally effective [...]